Tesamorelin × Peptide Partners — lab test, September 2026
COA G22ANYL113K1 matches Chromate's public record. So this test doesn't rest on our review alone — the lab confirms it too.
G22ANYL113K1Test results
Not on file for this certificate: sterility. A purity figure says nothing about that.
About this test
Label 10 mg · Lab measured 9.509 mg
95% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.4 mg using the measured mass, against 2.5 mg on the label — 5% less.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | G22ANYL113K1 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Chromate's portal shows validity only |
| Submitted via | Peptigrity staff |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tesamorelin from Peptide Partners, performed by Chromate on September 22, 2026. Reported purity: 99.437%. Net content: 9.509 mg against 10 mg labeled (95% of label). Endotoxins: < 5 EU/vial. Heavy metals: < 50 ppb. Batch TES2623. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Tesamorelin from Peptide Partners
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| Tes2624 | 15 Oct 2026 | Chromate | 99.204% | 95% | Unverified |
| TES202604 | 21 Apr 2026 | Kovera Labs | 99.851% | 116% | Unverified |
| TES202603 | 25 Mar 2026 | TrustPointe Analytics | 99.506% | 97% | Unverified |
| TES202601 | 6 Jan 2026 | TrustPointe Analytics | 99.713% | 113% | Unverified |
| TS20250722 | 22 Aug 2025 | TrustPointe Analytics | 99.104% | 99% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion